Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2022-02-01 00:00:00 ET · period of report 2022-01-30 · accession 0001209191-22-005838 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-01 | 2022-01-30 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $66.30 | -1,657 | 36.8K | -4% | -$109.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-30 | S | D | 1,657 | $66.30 | 36,759 | D | — | — | (F2) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |